Home › Hereditary Sensory and Autonomic Neuropathies › New York › New York City
Hereditary Sensory and Autonomic Neuropathies clinical trials in New York City, NY
6 studies for Hereditary Sensory and Autonomic Neuropathies are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
RecruitingPhase 2
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
The Natural History of Familial Dysautonomia
RecruitingObservational study
- Dysautonomia Center - School of Medicine -NYU Langone Medical Center, New York
The Cancer of the Pancreas Screening-5 CAPS5)Study
RecruitingPhase 3
- NYU Langone Medical Center, New York
- Columbia University Medical Center, New York
Hereditary Sensory and Autonomic Neuropathies trials in other cities
- San Antonio, TX7 studies
- Arlington, VA7 studies
- Boston, MA6 studies
- Nashville, TN6 studies
- Houston, TX5 studies
- Philadelphia, PA5 studies
- Portland, OR4 studies
- Pittsburgh, PA4 studies
- Ann Arbor, MI4 studies
- Washington, DC4 studies
- Aurora, CO3 studies
- San Francisco, CA3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.